Increased IL-23 Receptor+ T Cells in Lupus Patients
Author Information
Author(s): Puwipirom Hathaipat, Hirankarn Nattiya, Sodsai Pimpayao, Avihingsanon Yingyos, Wongpiyabovorn Jongkonnee, Palaga Tanapat
Primary Institution: Chulalongkorn University
Hypothesis
The study investigates the expression of IL-23R and IL-17 in T lymphocytes of patients with systemic lupus erythematosus (SLE).
Conclusion
The study confirmed that SLE patients have higher percentages of IL-23R+ T lymphocytes and that these cells are associated with disease severity.
Supporting Evidence
- SLE patients had significantly higher percentages of IL-23R+ CD4+ and CD8+ T cells compared to controls.
- The increase in IL-17+ T cells was significant after ex vivo stimulation in SLE patients.
- Positive correlations were found between IL-23R+ T cells and IL-17+ T cells in active SLE patients.
Takeaway
People with lupus have more special immune cells that can cause inflammation, which might make their disease worse.
Methodology
The study used flow cytometry to analyze IL-23R and IL-17 expression in T lymphocytes from peripheral blood mononuclear cells of SLE patients and control subjects.
Limitations
The study did not find significant differences in IL-17 levels in freshly isolated PBMCs between SLE patients and controls.
Participant Demographics
29 SLE patients (13 active, 16 inactive) and 10 control subjects, with a majority being female.
Statistical Information
P-Value
0.0021 for CD4+ and 0.0006 for CD8+ T cells
Statistical Significance
p<0.05
Digital Object Identifier (DOI)
Want to read the original?
Access the complete publication on the publisher's website